Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net loss	$ (7,600,197)	$ (3,294,441)
Adjustments to reconcile net loss to net cash used in operations:
Amortization expense	91,585	74,354
Lease expense	41,587	32,083
Depreciation expense	15,111	15,111
Stock options expense	705,030	1,109,603
Common stock issued for services	4,684,260
Changes in operating assets and liabilities:
Prepaid expenses	(62,779)	80,462
Prepaid expenses - noncurrent portion	(27,845)
Accounts payable	22,229	(87,232)
Investor deposits	300,000
Lease liability	(41,587)	(32,083)
Accrued expenses	105,011	186,606
Net cash used in operating activities	(1,767,595)	(1,915,537)
Cash flows from investing activities
Additions to intellectual property	(228,896)	(218,919)
Net cash used in investing activities	(228,896)	(218,919)
Cash flows from financing activities
Proceeds from issuance of common stock	5,308,000	1,920,000
Borrowing from related parties	112,359	900,000
Net cash provided by financing activities	5,420,359	2,820,000
Effect of exchange rate changes on cash	(68)
Net change in cash and cash equivalents	3,423,800	685,544
Cash and cash equivalents, beginning of period	350,565	219,781
Cash and cash equivalents, end of period	3,774,365	905,325
Supplementary disclosure for noncash activities:
Common stock issued for future services	$ 105,000